Moving drug candidates through the various phases of development is a complex process. It is necessary to analyze the drug’s effect on the whole cell rather than separate, individual constituents. The ...
Tia Harmon (left) is a Technical Product Sales Specialist in the cell and gene therapy (CGT) space at PHC Corporation of North America (PHCNA; IL, USA) with a background in cancer research. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback